S Squared Technology’s OptimizeRx OPRX Stock Holding History

S Squared Technology’s Portfolio OPRX Stock Details OPRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-17,021	Closed	-$243K	–	38
2023 Q2	$243K	Buy	+17,021	New	+$242K	0.12%	34
2021 Q3	–	Sell	-75,849	Closed	-$4.7M	–	36
2021 Q2	$4.7M	Sell	75,849 -5,744	-7%	-$292K	2.12%	22
2021 Q1	$3.98M	Sell	81,593 -77,798	-49%	-$3.75M	1.88%	24
2020 Q4	$4.97M	Sell	159,391 -39,109	-20%	-$958K	2.85%	16
2020 Q3	$4.14M	Sell	198,500 -27,836	-12%	-$478K	3.08%	12
2020 Q2	$2.95M	Sell	226,336 -41,900	-16%	-$455K	2.32%	18
2020 Q1	$2.43M	Buy	268,236 +64,261	+32%	+$610K	2.36%	19
2019 Q4	$2.1M	Buy	+203,975	New	+$2.31M	1.72%	30

Other funds holding OPRX

FLAM

First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return

AIC

AWM Investment Company New York $903M AUM 163.47% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

KCM

Kennedy Capital Management St Louis, Missouri $4.72B AUM 36.69% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

RHJA

Rice Hall James & Associates San Diego, California $1.8B AUM 36.16% 1-Year Est. Return

GIPM

G2 Investment Partners Management New York $406M AUM 164.47% 1-Year Est. Return

S Squared Technology's OPRX Position: Q3 2023 in Review

S Squared Technology sold out of OptimizeRx (OPRX) in Q3 2023, closing a stake of 17,021 shares — an estimated $243K sold.

S Squared Technology first reported a position in OPRX in Q4 2019 and held it in 8 quarters. The position peaked at $4.97M in Q4 2020. 94 funds tracked by Wall St. Rank hold OPRX as of Q3 2023.

S Squared Technology reported no remaining OptimizeRx position as of Q3 2023 after selling out during the quarter.
S Squared Technology sold 17,021 OptimizeRx shares in Q3 2023, an estimated $243K.
S Squared Technology first reported a position in OptimizeRx in Q4 2019 and held it in 8 quarters.
S Squared Technology's OptimizeRx position peaked at $4.97M in Q4 2020.
94 funds tracked by Wall St. Rank held OptimizeRx as of Q3 2023.

Based on S Squared Technology's 13F filing for Q3 2023, filed 13 Nov 2023.